Your session is about to expire
← Back to Search
Computerized Cognitive Tests for Early Detection of Alzheimer’s Disease
Study Summary
This trial will help develop computerized tests to detect early signs of cognitive decline in healthy people of different ages.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have a history of mental health issues.Spanish is my primary language.I can use a computer mouse and touch screen.I have a history of depression or anxiety.I can use a computer mouse and touch screen.I was hospitalized for a brain injury that made me lose consciousness for a long time.I have had a stroke or a transient ischemic attack.English is my primary language.You have a history of using drugs or alcohol in a harmful way.I have a history of epilepsy.
- Group 1: Test-Retest Reliability group
- Group 2: Health Disparities group
- Group 3: CCAB vs. manual test group
- Group 4: Older participant group
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does this research still accept volunteers?
"According to the clinicaltrials.gov database, this trial is currently in need of participants and was first published on May 1st 2021 with its last edit occurring on March 23rd 2021."
Is the age cutoff for this trial 85 or younger?
"To be considered for this study, patients must fall between the ages of 18 to 89. Additionally, there are 45 trials available specifically targeting individuals under the legal age and 1141 aimed at those with more advanced years."
Am I eligible to join this research endeavor?
"2000 people aged between 18 and 89, who are currently living with Alzheimer's disease, will be admitted into this trial. Additionally, the participants must demonstrate their ability to use a computer mouse and touchscreen interface."
What is the number of participants involved in this trial?
"Affirmative. Clinicaltrials.gov has the details on this clinical trial, which was originally listed in May 2021 and last updated in March of that same year. 2000 participants are needed from one specific medical centre for data collection purposes."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
How responsive is this trial?
Typically responds via
Most responsive sites:
- Neurobehavioral Systems, Inc.: < 24 hours
Average response time
- < 1 Day
Share this study with friends
Copy Link
Messenger